Literature DB >> 23453671

Is it time to write a prescription for coffee? Coffee and liver disease.

Dawn M Torres1, Stephen A Harrison.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23453671     DOI： 10.1053/j.gastro.2013.02.015

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  15 in total

Review 1.  Chemopreventive strategies in hepatocellular carcinoma.

Authors:  Siddharth Singh; Preet Paul Singh; Lewis R Roberts; William Sanchez
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-08-13       Impact factor: 46.802

2.  Associations of Coffee Drinking with Systemic Immune and Inflammatory Markers.

Authors:  Erikka Loftfield; Meredith S Shiels; Barry I Graubard; Hormuzd A Katki; Anil K Chaturvedi; Britton Trabert; Ligia A Pinto; Troy J Kemp; Fatma M Shebl; Susan T Mayne; Nicolas Wentzensen; Mark P Purdue; Allan Hildesheim; Rashmi Sinha; Neal D Freedman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-05-21       Impact factor: 4.254

Review 3.  Adenosinergic Signaling in Liver Fibrosis.

Authors:  Shilpa Tiwari-Heckler; Z Gordon Jiang
Journal:  Clin Liver Dis (Hoboken)       Date:  2019-08-02

4.  Coffee Is Not a Carcinogen.

Authors:  James J DiNicolantonio; James H O'Keefe
Journal:  Mo Med       Date:  2018 May-Jun

5.  Inverse associations of total and decaffeinated coffee with liver enzyme levels in National Health and Nutrition Examination Survey 1999-2010.

Authors:  Qian Xiao; Rashmi Sinha; Barry I Graubard; Neal D Freedman
Journal:  Hepatology       Date:  2014-10-30       Impact factor: 17.425

6.  How does coffee prevent liver fibrosis? Biological plausibility for recent epidemiological observations.

Authors:  Jonathan A Dranoff; Jordan J Feld; Elise G Lavoie; Michel Fausther
Journal:  Hepatology       Date:  2014-05-27       Impact factor: 17.425

Review 7.  Management of non-alcoholic fatty liver disease in 2015.

Authors:  Neel Malhotra; Melanie D Beaton
Journal:  World J Hepatol       Date:  2015-12-28

Review 8.  Oily fish, coffee and walnuts: Dietary treatment for nonalcoholic fatty liver disease.

Authors:  Vikas Gupta; Xian-Jun Mah; Maria Carmela Garcia; Christina Antonypillai; David van der Poorten
Journal:  World J Gastroenterol       Date:  2015-10-07       Impact factor: 5.742

9.  Association of coffee intake with reduced incidence of liver cancer and death from chronic liver disease in the US multiethnic cohort.

Authors:  Veronica Wendy Setiawan; Lynne R Wilkens; Shelly C Lu; Brenda Y Hernandez; Loïc Le Marchand; Brian E Henderson
Journal:  Gastroenterology       Date:  2014-10-08       Impact factor: 22.682

10.  Coffee, tea and decaffeinated coffee in relation to hepatocellular carcinoma in a European population: multicentre, prospective cohort study.

Authors:  Christina Bamia; Pagona Lagiou; Mazda Jenab; Antonia Trichopoulou; Veronika Fedirko; Krasimira Aleksandrova; Tobias Pischon; Kim Overvad; Anja Olsen; Anne Tjønneland; Marie-Christine Boutron-Ruault; Guy Fagherazzi; Antoine Racine; Tilman Kuhn; Heiner Boeing; Anna Floegel; Vasiliki Benetou; Domenico Palli; Sara Grioni; Salvatore Panico; Rosario Tumino; Paolo Vineis; H B Bueno-de-Mesquita; Vincent K Dik; Nirmala Bhoo-Pathy; Cuno S P M Uiterwaal; Elisabete Weiderpass; Eiliv Lund; J Ramón Quirós; Raul Zamora-Ros; Esther Molina-Montes; Maria-Dolores Chirlaque; Eva Ardanaz; Miren Dorronsoro; Björn Lindkvist; Peter Wallström; Lena Maria Nilsson; Malin Sund; Kay-Tee Khaw; Nick Wareham; Kathryn E Bradbury; Ruth C Travis; Pietro Ferrari; Talita Duarte-Salles; Magdalena Stepien; Marc Gunter; Neil Murphy; Elio Riboli; Dimitrios Trichopoulos
Journal:  Int J Cancer       Date:  2014-09-24       Impact factor: 7.396
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.